BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14642555)

  • 1. Follow-up care of women with an abnormal cytology in a low-resource setting.
    Gage JC; Ferreccio C; Gonzales M; Arroyo R; Huivín M; Robles SC
    Cancer Detect Prev; 2003; 27(6):466-71. PubMed ID: 14642555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do women comply with recommendations for Papanicolaou smears following colposcopy? A retrospective study.
    Martin JT
    J Midwifery Womens Health; 2008; 53(2):138-42. PubMed ID: 18308263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of Papanicolaou smear return in a hospital-based adolescent and young adult clinic.
    Kahn JA; Goodman E; Huang B; Slap GB; Emans SJ
    Obstet Gynecol; 2003 Mar; 101(3):490-9. PubMed ID: 12636952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
    Wright TC; Denny L; Kuhn L; Pollack A; Lorincz A
    JAMA; 2000 Jan; 283(1):81-6. PubMed ID: 10632284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers to follow-up of abnormal Papanicolaou smears among women in Leon, Nicaragua.
    Vastbinder MB; Castillo C; Bekkers RL
    Trop Doct; 2010 Jan; 40(1):22-6. PubMed ID: 20008060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of abnormal cervical and vaginal cytology among women over age 65 years living with human immunodeficiency virus.
    Stewart KA; Allen SM; Chesnokova AE; Syed F; Levison JE
    Am J Obstet Gynecol; 2020 May; 222(5):486.e1-486.e10. PubMed ID: 31678094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of management of high-grade cervical lesions in a single visit: a randomized controlled trial.
    Brewster WR; Hubbell FA; Largent J; Ziogas A; Lin F; Howe S; Ganiats TG; Anton-Culver H; Manetta A
    JAMA; 2005 Nov; 294(17):2182-7. PubMed ID: 16264159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Race-specific results of Papanicolaou testing and the rate of cervical neoplasia in the National Breast and Cervical Cancer Early Detection Program, 1991-1998 (United States).
    Benard VB; Lee NC; Piper M; Richardson L
    Cancer Causes Control; 2001 Jan; 12(1):61-8. PubMed ID: 11227926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensified screening among high risk women within the organised screening programme for cervical cancer in Finland.
    Kotaniemi-Talonen L; Malila N; Anttila A; Nieminen P; Hakama M
    Acta Oncol; 2011 Jan; 50(1):106-11. PubMed ID: 20560860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
    Zhao D; Zhang L; Xie F; Peng D; Wei J; Jiang L; Zhang S; Qi D
    BMC Cancer; 2020 Aug; 20(1):810. PubMed ID: 32847541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
    Sherman ME; Lorincz AT; Scott DR; Wacholder S; Castle PE; Glass AG; Mielzynska-Lohnas I; Rush BB; Schiffman M
    J Natl Cancer Inst; 2003 Jan; 95(1):46-52. PubMed ID: 12509400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring and evaluation of a model demonstration project for the control of cervical cancer in Nakhon Phanom province, Thailand.
    Deerasamee S; Srivatanakul P; Sriplung H; Nilvachararung S; Tansuwan U; Pitakpraiwan P; Kaewkungwal J; Singhasivanon P; Nimnakorn P; Sankaranarayanan R
    Asian Pac J Cancer Prev; 2007; 8(4):547-56. PubMed ID: 18260727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of positive screening test results and agreement between cytology and human papillomavirus testing in primary cervical cancer screening in North-Western Romania.
    Şuteu O; Blaga ML; Nygård M; Leinonen MK; Nicula F; Păiş R; Coza D; Cadariu PA; Melnic A; Andreassen T; Hashim D; Weiderpass E
    Eur J Cancer Prev; 2020 Mar; 29(2):141-148. PubMed ID: 31033568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV immunisation and cervical screening--confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study.
    Palmer TJ; McFadden M; Pollock KG; Kavanagh K; Cuschieri K; Cruickshank M; Cotton S; Nicoll S; Robertson C
    Br J Cancer; 2016 Mar; 114(5):582-9. PubMed ID: 26931370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical cytology and HPV test in follow-up after conisation or LLETZ.
    Ostojić DV; Vrdoljak-Mozetic D; Stemberger-Papić S; Finderle A; Eminović S
    Coll Antropol; 2010 Mar; 34(1):219-24. PubMed ID: 20432754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the risks of CIN3+ detection after multiple rounds of HPV testing: Results of the 15-year cervical cancer screening experience at Kaiser Permanente Northern California.
    Hammer A; Demarco M; Campos N; Befano B; Gravitt PE; Cheung L; Lorey TS; Poitras N; Kinney W; Wentzensen N; Castle PE; Schiffman M
    Int J Cancer; 2020 Sep; 147(6):1612-1620. PubMed ID: 32141607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Following-up females having an abnormal Pap smear in Colombia].
    Wiesner C; Cendales R; Murillo R; Piñeros M; Tovar S
    Rev Salud Publica (Bogota); 2010 Feb; 12(1):1-13. PubMed ID: 20628695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
    Ogilvie GS; van Niekerk D; Krajden M; Smith LW; Cook D; Gondara L; Ceballos K; Quinlan D; Lee M; Martin RE; Gentile L; Peacock S; Stuart GCE; Franco EL; Coldman AJ
    JAMA; 2018 Jul; 320(1):43-52. PubMed ID: 29971397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One Pap smear of benefit in developing countries.
    Bagchi S
    Lancet Oncol; 2005 Jan; 6(1):9. PubMed ID: 15672493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.